BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31705190)

  • 21. Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases.
    Al-Ibraheemi A; Folpe AL; Perez-Atayde AR; Perry K; Hofvander J; Arbajian E; Magnusson L; Nilsson J; Mertens F
    Mod Pathol; 2019 Mar; 32(3):423-434. PubMed ID: 30310176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
    Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
    Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics.
    Karamzadeh Dashti N; Bahrami A; Lee SJ; Jenkins SM; Rodriguez FJ; Folpe AL; Boland JM
    Am J Surg Pathol; 2017 Nov; 41(11):1532-1541. PubMed ID: 28834810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.
    Pond D; Arts FA; Mendelsohn NJ; Demoulin JB; Scharer G; Messinger Y
    Genet Med; 2018 Jan; 20(1):142-150. PubMed ID: 28726812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myopericytomatosis: Clinicopathologic Analysis of 11 Cases With Molecular Identification of Recurrent PDGFRB Alterations in Myopericytomatosis and Myopericytoma.
    Hung YP; Fletcher CDM
    Am J Surg Pathol; 2017 Aug; 41(8):1034-1044. PubMed ID: 28505006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraneural glomus tumor of "uncertain malignant potential" and with BRAF mutation in the median nerve - an unusual case.
    Dahlin LB; Scherman P; Besjakov J; Lindberg E; Solomon DA; Horvai AE; Perry A
    Clin Neuropathol; 2017; 36(4):164-170. PubMed ID: 28438258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR Exon 20 Insertion/Duplication Mutation in Fibrous Hamartoma of Infancy With Predominantly Pseudoangiomatous Pattern Mimicking Giant Cell Fibroblastoma.
    Ellington N; Park JY; King K; Josephs S; Rakheja D
    Int J Surg Pathol; 2017 Aug; 25(5):421-424. PubMed ID: 28381148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
    Arts FA; Sciot R; Brichard B; Renard M; de Rocca Serra A; Dachy G; Noël LA; Velghe AI; Galant C; Debiec-Rychter M; Van Damme A; Vikkula M; Helaers R; Limaye N; Poirel HA; Demoulin JB
    Hum Mol Genet; 2017 May; 26(10):1801-1810. PubMed ID: 28334876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.
    Antonescu CR; Sung YS; Zhang L; Agaram NP; Fletcher CD
    Am J Surg Pathol; 2017 May; 41(5):677-684. PubMed ID: 28248815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
    Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
    BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features.
    Al-Ibraheemi A; Martinez A; Weiss SW; Kozakewich HP; Perez-Atayde AR; Tran H; Parham DM; Sukov WR; Fritchie KJ; Folpe AL
    Mod Pathol; 2017 Apr; 30(4):474-485. PubMed ID: 28059097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment.
    Li J; Cai J; Zhao S; Yao K; Sun Y; Li Y; Chen L; Li R; Zhai X; Zhang J; Jiang C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):184. PubMed ID: 27894350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
    Agaimy A; Bieg M; Michal M; Geddert H; Märkl B; Seitz J; Moskalev EA; Schlesner M; Metzler M; Hartmann A; Wiemann S; Michal M; Mentzel T; Haller F
    Am J Surg Pathol; 2017 Feb; 41(2):195-203. PubMed ID: 27776010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR Exon 20 Insertion/Duplication Mutations Characterize Fibrous Hamartoma of Infancy.
    Park JY; Cohen C; Lopez D; Ramos E; Wagenfuehr J; Rakheja D
    Am J Surg Pathol; 2016 Dec; 40(12):1713-1718. PubMed ID: 27631514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax.
    Vlčková K; Réda J; Ondrušová L; Krayem M; Ghanem G; Vachtenheim J
    Int J Oncol; 2016 Sep; 49(3):953-60. PubMed ID: 27572939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Response Factor in Muscle Tissues: From Development to Ageing.
    Coletti D; Daou N; Hassani M; Li Z; Parlakian A
    Eur J Transl Myol; 2016 Jun; 26(2):6008. PubMed ID: 27478561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.
    Geng L; Lu K; Li P; Li X; Zhou X; Li Y; Wang X
    Oncotarget; 2017 Jul; 8(30):48701-48710. PubMed ID: 27275540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocation t(7;12) as the sole chromosomal abnormality resulting in ACTB-GLI1 fusion in pediatric gastric pericytoma.
    Castro E; Cortes-Santiago N; Ferguson LM; Rao PH; Venkatramani R; López-Terrada D
    Hum Pathol; 2016 Jul; 53():137-41. PubMed ID: 26980027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma.
    Puls F; Hofvander J; Magnusson L; Nilsson J; Haywood E; Sumathi VP; Mangham DC; Kindblom LG; Mertens F
    J Pathol; 2016 Mar; 238(4):502-7. PubMed ID: 26691015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.
    Arts FA; Chand D; Pecquet C; Velghe AI; Constantinescu S; Hallberg B; Demoulin JB
    Oncogene; 2016 Jun; 35(25):3239-48. PubMed ID: 26455322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.